A prospective survey on falls in persons with type 2 diabetes was conducted at 1-year intervals for up to 5 years after discharge to investigate the association of SGLT2 inhibitor and GLP-1RA intake on fall incidence. Here, SLC5A2 is linked to type 2 diabetes mellitus.